Excellence in Bioscience Publishing
From The Federation of European Biochemical Societies
Discover the FEBS journals today!
• ViewFREE sample issues• Readthetop cited articles• Readthetopaccessed articles• SignupforFREE Content Alerting
The FEBS Journal is an international journal devoted to the rapid publication of full-length papers and reviews covering a broad spectrum of topics in the molecular life sciences. The FEBS Journal publishes in many areas including, but not limited to, structural biology, cell and molecular biology, immunology, bioinformatics, systems biology, genomics and proteomics, chemical biology, and the molecular basis of disease.
The FEBS Journal offers authors:
• Distinguished international Editorial Board
• Fast and helpful peer review
• No page charges and free colour figures
• Immediate free access to Reviews and Minireviews
• High visibility of published papers
• Open Access option
• Time to first decision normally less than 30 days
• The FEBS Journal Prize for Young Scientists
Keep up to date:
• Sign up for content alerts
• Read the latest articles published
• Read the most cited articles
• Read the most read articles
• Read the current sample copy
www.febsjournal.org
Special Issues
Frontiers in Cell Signalling, and Ca2+ Signalling and Transport in Health and Disease
Myogenesis
Catalytic Mechanisms by Biological Systems
Proteoglycans: Signaling, Targeting and Therapeutics
Read these and more at www.febsjournal.org
Enzyme Catalysis and Allostery: A Century of Advances in Molecular Understanding
Vol 281, Issue 2 (January 2014)
Edited by Athel Cornish-Bowden
Virtual Issues
MicroRNA
Systems Biology
Structural Biology
Molecular Enzymology
Read these and more at www.febsjournal.org
Epigenetics
November 2013
Edited by Pura Muñoz-Cánoves
Editor-in-Chief:SeamusMartinEditorialoffice:Cambridge,UK
Molecular Oncology highlights new discoveries, approaches, as well as technical developments, in basic, clinical and discovery-driven translational research. A main feature of the journal is to provide an international forum for debating cancer issues, and for integrating the input of all the stakeholders.
www.elsevier.com/locate/molonc
Molecular Oncology offers authors:
• No page charges and free colour
• Fast review time, less than 3 weeks
• Accepted articles published online within 5 days, to deliver your work to its audience as quickly as possible
• Connection with an audience of global cancer experts and stakeholders
• Comprehensive and constructive advice for improvements to papers
• Fully automated submission system, allowing you to track the progress of your paper
• Open Access options
Keep up to date:
• Sign up for content alerts
• Read the latest articles published
• Read the most cited articles
• Read the most read articles
• Read the open archive articles
Editor-in-Chief:J.E.CelisEditorialoffice:Copenhagen,Denmark
Special Issues Published Special Issues
Critical issues on biomarkers discovery and validation
Edited by Alan Spatz and Leon van Kempen
Drug resistance in cancer
Edited by Daniel Peeper
Innovative clinical trials for development of personalized cancer medicine
Edited by Ulrik Ringborg, Richard Schilsky, and John Mendelsohn
Mouse models of cancer: Essential tools for better therapies
Volume 7, Issue 2 (April 2013)
Edited by Mariano Barbacid and Anton Berns
Molecular Oncology highlights new discoveries, approaches, as well as technical developments, in basic, clinical and discovery-driven translational research. A main feature of the journal is to provide an international forum for debating cancer issues, and for integrating the input of all the stakeholders.
www.elsevier.com/locate/molonc
Molecular Oncology offers authors:
• No page charges and free colour
• Fast review time, less than 3 weeks
• Accepted articles published online within 5 days, to deliver your work to its audience as quickly as possible
• Connection with an audience of global cancer experts and stakeholders
• Comprehensive and constructive advice for improvements to papers
• Fully automated submission system, allowing you to track the progress of your paper
• Open Access options
Keep up to date:
• Sign up for content alerts
• Read the latest articles published
• Read the most cited articles
• Read the most read articles
• Read the open archive articles
Editor-in-Chief:J.E.CelisEditorialoffice:Copenhagen,Denmark
Special Issues Published Special Issues
Critical issues on biomarkers discovery and validation
Edited by Alan Spatz and Leon van Kempen
Drug resistance in cancer
Edited by Daniel Peeper
Innovative clinical trials for development of personalized cancer medicine
Edited by Ulrik Ringborg, Richard Schilsky, and John Mendelsohn
Mouse models of cancer: Essential tools for better therapies
Volume 7, Issue 2 (April 2013)
Edited by Mariano Barbacid and Anton Berns
www.elsevier.com/locate/febsopenbio
FEBS Open Bio is an online-only Open Access journal for the rapid publication of research articles in molecular and cellular life sciences in both health and disease. The journal’s peer review process focuses on the technical soundness of papers, leaving the assessment of their impact and importance to the scientific community.
FEBS Open Bio offers authors:
• Easyonlinemanuscriptsubmissionand tracking system
• Fastandhelpfulpeerreview–mediantimetofirst decision 23 days in 2013
• TransferserviceforarticlesfromotherFEBSjournals, conserving peer reviews
• OpenAccesspublication
• AchoiceofCreativeCommonslicenses
• AllarticlesdepositedinPubMedCentralandindexed in PubMed
• HTMLenhancements,including3Dmolecularviewer
• Rapid,singlearticlepublication
Keep up to date:
• Sign up for content alerts
• Read the latest articles published
• Read the most cited articles
• Read the most read articles
ExecutiveEditor:MaryPurtonEditorialoffice:Cambridge,UK
www.elsevier.com/locate/febsopenbio
FEBS Open Bio is an online-only Open Access journal for the rapid publication of research articles in molecular and cellular life sciences in both health and disease. The journal’s peer review process focuses on the technical soundness of papers, leaving the assessment of their impact and importance to the scientific community.
FEBS Open Bio offers authors:
• Easyonlinemanuscriptsubmissionand tracking system
• Fastandhelpfulpeerreview–mediantimetofirst decision 23 days in 2013
• TransferserviceforarticlesfromotherFEBSjournals, conserving peer reviews
• OpenAccesspublication
• AchoiceofCreativeCommonslicenses
• AllarticlesdepositedinPubMedCentralandindexed in PubMed
• HTMLenhancements,including3Dmolecularviewer
• Rapid,singlearticlepublication
Keep up to date:
• Sign up for content alerts
• Read the latest articles published
• Read the most cited articles
• Read the most read articles
ExecutiveEditor:MaryPurtonEditorialoffice:Cambridge,UK
FEBS Letters offers authors:
• Competent manuscript reviewing
• Easy online submission system
• No page charges and free colour figures
• Open Access options
• Special Issues
• Fast-track manuscript handling
• Young Group Leader Award and Scientist Award
FEBS Letters is a world-renowned journal for the rapid publication of short reports describing novel and specific effects with a biologically or biochemically significant function. Bringing together the most important developments in the molecular biosciences, FEBS Letters provides an international forum with high-quality Reviews on cutting-edge science, in addition to Research Letters and Hypotheses of broad interest.
www.elsevier.com/locate/febslet
Special Issues Published Special Issues
Tumor Suppressors
Edited by Shairaz Baksh, Giovanni Blandino and Wilhelm Just
Gut Microbiome
Edited by Lloyd Kasper and Wilhelm Just
Single Molecule Fluorescence
Edited by Elias Puchner, Bo Huang and Herman Gaub
FEBS Congress, Paris Special Issue
Edited by Wilhelm Just
Junctional Proteins
Volume 588, Issue 8, April 2014
Edited by Michael Koval, Brant Isakson, Rob Gourdie and Wilhelm Just
Protein Engineering
Volume 588, Issue 2, January 2014
Edited by Wilhelm Just
Keep up to date:
• Sign up for content alerts
• Read the latest articles published
• Read the most cited articles
• Read the most read articles
• Read the open archive articles
ManagingEditor:FelixWielandEditorialoffice:Heidelberg,Germany
The Latest Results and Discussions Across the Molecular Life Sciences
• Esteemed international Editorial Boards
• High-quality peer review
• Research articles, reviews, Special Issues, Virtual Issues and more
• Fast publication
• Innovative features including database linking, structured digital abstracts, enhanced html access and podcasts
• Highly cited and highly accessed content
• Open Access options
Awards for Outstanding Papers – Read all about it!• The FEBS Journal Prize bit.ly/FEBSJprize
• FEBS Letters Award bit.ly/FEBSLprize
FEBS is a charitable organization advancing research in the molecular life sciences across Europe and beyond. The publications are wholly owned by FEBS, and income from them funds FEBS programmes such as fellowships and courses.
FEBS is celebrating its 50th anniversary in 2014. Find out more at www.febs.org
Excellence in Bioscience Publishing
From The Federation of European Biochemical Societies
Discover the FEBS journals today!
• ViewFREE sample issues• Readthetop cited articles• Readthetopaccessed articles• SignupforFREE Content Alerting
The Latest Results and Discussions Across the Molecular Life Sciences
• Esteemed international Editorial Boards
• High-quality peer review
• Research articles, reviews, Special Issues, Virtual Issues and more
• Fast publication
• Innovative features including database linking, structured digital abstracts, enhanced html access and podcasts
• Highly cited and highly accessed content
• Open Access options
Awards for Outstanding Papers – Read all about it!• The FEBS Journal Prize bit.ly/FEBSJprize
• FEBS Letters Award bit.ly/FEBSLprize
FEBS is a charitable organization advancing research in the molecular life sciences across Europe and beyond. The publications are wholly owned by FEBS, and income from them funds FEBS programmes such as fellowships and courses.
FEBS is celebrating its 50th anniversary in 2014. Find out more at www.febs.org
14
-6
63
44